SWANWOOD PARTNERSHIP
2 MARKET AVENUE, WICKFORDCHD005
The percentage of patients with coronary heart disease with a record in the preceding 12 months that aspirin, an alternative anti-platelet therapy, or an anti-coagulant is being taken
Indicator | Year | Numerator | Denominator | Ratio | Centile |
---|---|---|---|---|---|
CHD 9 | 2005 | 46 | 46 | 100.0% | |
CHD 9 | 2006 | 49 | 49 | 100.0% | |
CHD 9 | 2007 | 48 | 50 | 96.0% | |
CHD 9 | 2008 | 44 | 46 | 95.7% | |
CHD 9 | 2009 | 42 | 45 | 93.3% | |
CHD 9 | 2010 | 45 | 46 | 97.8% | |
CHD 9 | 2011 | 43 | 46 | 93.5% | |
CHD 9 | 2012 | 40 | 44 | 90.9% | |
CHD 9 | 2013 | 41 | 43 | 95.3% | |
CHD005 | 2014 | 41 | 44 | 93.2% | |
CHD005 | 2015 | 50 | 51 | 98.0% | |
CHD005 | 2016 | 177 | 185 | 95.7% | |
CHD005 | 2017 | 183 | 208 | 88.0% | |
CHD005 | 2018 | 212 | 251 | 84.5% | |
CHD005 | 2019 | 197 | 230 | 85.7% | |
CHD005 | 2020 | 213 | 224 | 95.1% | |
CHD005 | 2021 | 195 | 224 | 87.1% | |
CHD005 | 2022 | 205 | 212 | 96.7% | |
CHD005 | 2023 | 200 | 203 | 98.5% |